Company has been in the pits for quite some time, trading at cash levels .. market is saying the IP is worthless despite having multiple clinical trials in progress and previous offers of $200M .
Sucks for exisiting long term holders but prime opportunity for new investors to get in at very attractive risk reward ratio.
Ann: Initial Results in First 16 DFU Patients Expected in Q1 2024, page-2
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
27.5¢ |
Change
0.005(1.85%) |
Mkt cap ! $49.39M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 28.0¢ | 27.5¢ | $6.183K | 22.08K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 27.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.0¢ | 32514 | 3 |
View Market Depth
| Last trade - 11.18am 24/05/2024 (20 minute delay) ? |
|
|||||
|
Last
27.5¢ |
Change
0.005 ( 1.85 %) |
||||
| Open | High | Low | Volume | ||
| 28.0¢ | 28.0¢ | 27.0¢ | 21201 | ||
| Last updated 15.59pm 24/05/2024 ? | |||||
| CYP (ASX) Chart |